Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of Tipranavir-treated primary tumor-derived human gastric cancer stem cells (GCSCs)

ABSTRACT: RNA-seq of Tipranavir-treated primary tumor-derived human gastric cancer stem cells (GCSCs)

PROVIDER: PRJNA679578 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13086516_1.fastq.gz	Fastqsanger.gz
	SRR13086516_2.fastq.gz	Fastqsanger.gz
	SRR13086517_1.fastq.gz	Fastqsanger.gz
	SRR13086517_2.fastq.gz	Fastqsanger.gz
	SRR13086518_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

RNA-seq of primary tumor-derived human gastric cancer stem cells (GCSCs) and differentiated cells (GCSCs treated with serum)

Project description:RNA-seq of primary tumor-derived human gastric cancer stem cells (GCSCs) and differentiated cells (GCSCs treated with serum)

| PRJNA864830 | ENA

RNA-seq of Tipranavir-treated primary tumor-derived human gastric cancer stem cells (GCSCs)

Project description:We performed RNA-seq analysis of human gastric cancer stem cell treated with or without Tipranavir to elucidate the effect of Tipranavir on GCSCs, and find Tipranavir's potential targets in GCSCs.

2021-07-31 | GSE161825 | GEO

Expression profiling of frozen primary and patient derived xenograft gastric cancer

Project description:Expression profiling of frozen primary and patient derived xenograft gastric cancer

2019-10-15 | GSE98708 | GEO

RNA-seq of primary tumor-derived human gastric cancer stem cells (GCSCs) and differentiated cells (GCSCs treated with serum)

Project description:We performed RNA-seq analysis of human gastric cancer stem cell treated with or without serum to analyze the differentially expressed genes between GCSCs and differentiated cells, and find the potential key factors in GCSCs.

2023-03-01 | GSE210249 | GEO

Gene expression signatures for primary tumor and tumor-derived exosomes

Project description:To determine the different gene signatures between primary tumor and tumor-derived exosomes, we have employed RNA-sequencing as a discovery platform to identify gene signatures of tumor-derived exosomes, taking the original tumors as a control. We subcutaneously inoculated C57BL/6 mice with Lewis lung carcinoma (LLC). Three weeks later, tumor tissues were cut and tumor-derived exosomes were isolated as described in the "treatment protocol". Then, both exosomal RNA and tumor RNA were extracted and sequenced. From sequencing, we found that exosomal RNAs showed quite different transcript profiles from tumor RNAs. Examination of different gene signatures between primary tumor and tumor-derived exosomes. 2 replicates each.

2016-08-10 | E-GEOD-80678 | biostudies-arrayexpress

Comparing Wilms tumor primary samples to patient-derived xenografts

Project description:Comparing Wilms tumor primary samples to patient-derived xenografts

| PRJNA434302 | ENA

Human fetal and pediatric primary gastric samples and organoids derived from them

Project description:Human fetal and pediatric primary gastric samples and organoids derived from them

| PRJNA643724 | ENA

Gene expression signatures for primary tumor and tumor-derived exosomes

2016-08-10 | GSE80678 | GEO

Altered 5-hydroxymethylcytosine landscape in primary gastric adenocarcinoma

Project description:Multiple factors, including molecular, genetic, and epigenetic changes, have been linked to gastric cancer formation and progression. Cytosine methylation (5mC) has been well studied and recognized as a critical epigenetic mark in the mammalian genome. The recent novel discovery of 5-hydroxymethylcytosine (5hmC), which generated by ten-eleven translocation (TET) enzymes, provide new perspective to understand DNA methylation-related plasticity. Here we show that gastric tumors display significant loss of 5hmC. Using matched distant normal, peripheral and tumor primary tissues, we performed genome-wide profiling of 5hmC and identified differentially hydroxymethylated regions (DhMRs) specifically associated with gastric tumors. Gene Ontology (GO) analyses indicated that DhMRs (both loss-of-5hmC and gain-of-5hmC) were enriched among the genes involved in specific pathways. Interestingly the binding motif of hypoxia-inducible factor 1 (HIF1) is enriched among both peripheral and tumor DhMRs, while the Myc-binding motif is specifically enriched among only tumor DhMRs. Tumor progression analyses revealed a unique set of DhMRs that correlate with tumor progression. These data together suggest that the alteration of 5hmC could potentially contribute to the tumorigenesis of gastric tumors.

2019-12-09 | GSE134927 | GEO

Human fetal and pediatric primary gastric samples and organoids derived from them

Project description:Reliable modelling of human stomach development and in vitro derivation of mature subsets of gastric epithelial cells has been challenging to achieve in 3D cultures. We derived fetal gastric organoid cultures from 8-20 post-conception week (PCW) stomachs, and post-natal controls from pediatric biopsies.

2020-10-01 | GSE153698 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data